With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid...
As a global recession looms, many businesses find themselves facing an existential crisis. The coronavirus pandemic has signalled an end to a period of untrammelled economic...
By European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan Clinical trials are vital to patients and the advancement of cures for myriad diseases, but...
Opinion by EHFG President Helmut Brand and EAPM Executive Director Denis Horgan Everybody likes to get a fair deal. Nobody wants to feel they have been...
By Anastassia Negrouk, Head of International Regulatory and Intergroup Office, EORTC, Chair of European Alliance for Personalised Medicine (EAPM) Working Group on Regulatory Affairs, Magdda Chlebus,...
On 2 April, the European Parliament voted for a wide-ranging package of transparency measures for clinical trial data, measures that give hope to patients suffering from...
European Agenda is provided by Orpheus Public Affairs European Parliament – Committee Week, Brussels 20-22 January European Parliamentary Week, click here to see the draft programme...
